| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6060382 | Sleep Medicine | 2015 | 7 Pages |
Abstract
The efficacy of JZP-110 for impaired wakefulness and excessive sleepiness was observed at 150-300âmg/day and as early as one week after initiating treatment (Clinicaltrials.gov identifier NCT01485770).
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Richard K. Bogan, Neil Feldman, Helene A. Emsellem, Russell Rosenberg, Yuan Lu, Gary Bream, Moise Khayrallah, D. Alan Lankford,